Quality Care India Ltd, one of India’s leading healthcare platforms, has received the letter of acceptance (LoA) for the development of a 350+ bed multi-speciality hospital in Nagpur, marking a significant milestone in strengthening healthcare infrastructure in Maharashtra and Central India, the healthcare firm said in a release.

The LoA was exchanged between Maha-Metro and Quality Care India in the presence of Chief Minister Devendra Fadnavis and Union Minister Nitin Gadkari during the Advantage Vidarbha event in Nagpur.

The proposed Care hospital will be developed on Maha-Metro land near Kasturchand Park Metro Station in Nagpur, a key urban and transit hub in the city, the release said.

As part of the project, Quality Care India Limited will invest approximately Rs 600 crore towards hospital development, creating a future-ready healthcare facility designed to serve both Nagpur and the surrounding regions, it added.

Live Events

“This project reflects the growing importance of structured public-private partnerships in building healthcare systems that are accessible, integrated, and sustainable. By aligning healthcare infrastructure with urban development, we can create scalable models that deliver high-quality care beyond metros.
“For cities like Nagpur, such collaborations are critical to strengthening regional healthcare capacity and addressing the long-term needs of Tier 2 and Tier 3 markets,” Quality Care India Group Managing Director Varun Khanna said.The hospital is expected to become operational in a phased manner and is anticipated to create over 1,500 direct and indirect employment opportunities, while strengthening Vidarbha as a regional healthcare destination.

It will feature specialised centres of excellence across cardiac sciences, oncology, Gastroenterology, trauma care and neurosciences, bringing advanced medical care closer to patients in Central India.

The 30-share BSE Sensex rose 187.95 points, or 0.22 per cent, over the past week.

Larsen & Toubro, State Bank of India (SBI), HDFC Bank, Life Insurance Corporation of India (LIC), Bajaj Finance, and Reliance Industries were the gainers, while Bharti Airtel, ICICI Bank, Infosys, and Tata Consultancy Services saw their valuations erode.

The market valuation of Larsen & Toubro jumped by Rs 28,523.31 crore to Rs 6,02,552.24 crore. SBI added Rs 16,015.12 crore to Rs 11,22,581.56 crore.

The valuation of HDFC Bank climbed by Rs 9,617.56 crore to Rs 14,03,239.48 crore, and that of LIC edged higher by Rs 5,977.12 crore to Rs 5,52,203.92 crore.

Live Events

The market capitalisation (mcap) of Bajaj Finance advanced Rs 3,142.36 crore to Rs 6,40,387 crore, and that of Reliance Industries went up Rs 202.99 crore to Rs 19,21,678.78 crore.
However, the mcap of Bharti Airtel tumbled Rs 15,338.66 crore to Rs 11,27,705.37 crore.The valuation of ICICI Bank eroded by Rs 14,632.10 crore to Rs 9,97,346.67 crore.

Infosys’ mcap declined by Rs 6,791.58 crore to Rs 5,48,496.14 crore and that of Tata Consultancy Services (TCS) dipped Rs 1,989.95 crore to Rs 9,72,053.48 crore.

Reliance Industries remained the most-valued firm, followed by HDFC Bank, Bharti Airtel, State Bank of India, ICICI Bank, Tata Consultancy Services, Bajaj Finance, Larsen & Toubro, Life Insurance Corporation of India, and Infosys.

This article was written by

Follow

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Copyright ©2026 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8